Hydrogels have emerged as potential drug delivery carriers for peptides and proteins, which can protect protein/peptide bioactive molecules from degradation and release them from the hydrogel matrix in a controlled manner over a long period of time. As a solution provider for the development of innovative protein/peptide delivery systems, CD Formulation has established a versatile macromolecular hydrogel delivery platform that can be designed and developed for the delivery of different types of protein and peptide drugs.
Hydrogel is a three-dimensional hydrophilic polymer network composed of cross-linked water-soluble polymer chains, which can absorb a large amount of water but are insoluble in water and biological fluids.
Hydrogel-based drug carriers are an emerging protein/peptide delivery system. The hydrogel delivery system uses non-toxic, biocompatible, and biodegradable water-soluble polymers as carriers or media to chemically or physically combine with proteins/peptides to form corresponding drug dosage forms. The hydrogel delivery system enters the body through chemical diffusion or penetration, and releases proteins/peptides slowly and continuously into the human body at a stable rate and appropriate concentration, thereby improving the efficacy of the drug, reducing the dosage of the drug, and achieving the best therapeutic effect. Different polymer-carriers, as one of the important components of the hydrogel system, have different delivery characteristics and sustained-release properties for proteins/peptides. Hydrogels can be made of polymers of various shapes and forms and are designed to respond to various physiological stimuli, enabling the controlled and targeted release of encapsulated peptides and proteins over a long period.
Fig. 1 Protein/peptide therapeutic (orange spheres) encapsulated in a hydrogel. (CD Formulation)
As an expert in protein/peptide science and formulation science, CD Formulation has the most advanced industry knowledge and technology in protein and peptide delivery and is committed to providing you with comprehensive, innovative, and systematic hydrogel delivery system development solutions.
Our experienced team of scientists is good at using a variety of hydrogel materials, such as chitosan, alginate, and N-isopropyl acrylamide (NIPAM) to customize and develop powerful innovative hydrogel delivery systems for you to meet your specific needs.
Available hydrogel materials include:
Thanks to years of continuous exploration of hydrogel systems, we have established an advanced and systematic hydrogel platform that can design and develop protein/peptide hydrogel delivery systems with different properties, including:
Depending on the clinical application and disease area, these hydrogel delivery systems are designed by our scientists to enter the body in different ways, including:
Fig. 2 Administration routes of hydrogel protein/peptide delivery systems. (CD Formulation)
In order to make the hydrogel have certain biodegradability and sufficient strength, our team of formulation scientists uses various types of physical and chemical methods to crosslink the hydrogel, including:
Fig. 3 Chemical and physical crosslinking of hydrogels. (Lei L, et al., 2022)
Published Data
Technology: Hydrogels Delivery Technology
Journal: Gels
IF: 4.43
Published: 2023
Results:
The authors selected poly(lactide-co-glycolide)-b-poly(ethylene glycol)-b-poly(lactide-co-glycolide) as the hydrogel matrix and evaluated the effect of this hydrogel formulation as a controlled delivery system for various peptides and proteins, including insulin, glucagon-like peptide analogs, bovine serum albumin, and immunoglobulin G. The thermosensitivity and gelation properties of the hydrogel formulation was characterized by dynamic light scattering (DLS) and oscillatory rheology. The biophysical stability and conformational properties of these released proteins were evaluated by size exclusion chromatography (SEC) and circular dichroism (CD). The hypoglycemic efficacy and pharmacokinetics of hydrogel formulations encapsulating therapeutic glucagon-like peptide analogs were evaluated by subcutaneous injection in diabetic mice and minipig models. The results showed that the peptide release profile in the peptide-loaded hydrogel formulation was better and the hypoglycemic effect was sustained. This indicates that the PLGA-PEG-PLGA hydrogel formulation has excellent therapeutic potential.
Fig. 4 Structure and preparation of PLGA–PEG–PLGA hydrogel with therapeutic peptides, and in vivo efficacy and pharmacokinetics studies in diabetic animal models. (Malta R, et al., 2023)
CD Formulation is continually researching and developing new technologies to improve protein/peptide hydrogel delivery systems. Our scientists stay up to date on the latest advances in the field to provide you with innovative solutions that can enhance protein and peptide delivery. Please don't hesitate to contact us if you are interested in our services.
References